|
Bextra®
Philadelphia.
If
you are currently on Bextra check with your doctor, especially
if you have a history of heart problems.
Withdrawal
On
April 7, 2005 the FDA announced that it has asked Pfizer, Inc.
to withdraw Bextra from the market
"because the overall risk versus benefit profile for the
drug is unfavorable."
Bextra® is
a COX-2 selective agent. It is
prescribed for inflammation and pain from arthritis or menstrual
cramping. Other drugs in this class include Celebrex® and
Vioxx®. Bextra® and Celebrex® are both marketed by
Pharmacia Corporation and Pfizer. Vioxx® is manufactured by Merck. Doctors switched patients
from Vioxx® to Bextra® when Merck voluntarily removed it from the
market due studies showing an increased risk for heart attack
and stroke.
bextra
site map
For attorney information check
these sites out:
For
further information from the government's Food and Drug
Administration try these sites:
Autism
Education Materials!
|
